En
CN
EN
Investor Relations
Information disclosure
Stock Information
Presentation Materials and Newsletter
Corporate Governance
Investor Calendar
Investor Enquiries
Peijia Medical Announced 2022 Interim Results
2022-08-23 10:11:51
Prev：
Asia’s first successful clinical case using HighLife transseptal mitral valve replacement technolog
Next：
Bimonthly Newsletter Vol.4 2022
Top
